Screening compound: UFWXSFSMIFKKPH-QFIPXVFZSA-N

Screening compound: UFWXSFSMIFKKPH-QFIPXVFZSA-N
Screening compound: UFWXSFSMIFKKPH-QFIPXVFZSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
UFWXSFSMIFKKPH-QFIPXVFZSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T787-6323

Molecular Formula

C25H31N3O3 (C25 H31 N3 O3)

Compound Name

2-(3,4-dimethylbenzoyl)-N-[2-(pyridin-4-yl)ethyl]-8-oxa-2-azaspiro[4.5]decane-4-carboxamide

IUPAC name

2-(34-dimethylbenzoyl)-N-[2-(pyridin-4-yl)ethyl]-8-oxa-2-azaspiro[4.5]decane-4-carboxamide

SMILES

Cc(cc1)c(C)cc1C(N(C1)CC2(CCOCC2)C1C(NCCc1ccncc1)=O)=O

InChI

InChI=1S/C25H31N3O3/c1-18-3-4-21(15-19(18)2)24(30)28-16-22(25(17-28)8-13-31-14-9-25)23(29)27-12-7-20-5-10-26-11-6-20/h3-6,10-11,15,22H,7-9,12-14,16-17H2,1-2H3,(H,27,29)/t22-/m0/s1

InChI Key

UFWXSFSMIFKKPH-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD28999555

UFWXSFSMIFKKPH-QFIPXVFZSA-N in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

3D-Diversity Natural-Product-Like Library (18102 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS BBB Library (22607 compounds)

CORONAVIRUS Library (20774 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Ion Channels Focused Library (26372 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Nervous system
  • Cardiovascular
  • Cancer
Structure:
  • 3D
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with UFWXSFSMIFKKPH-QFIPXVFZSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound UFWXSFSMIFKKPH-QFIPXVFZSA-N?
Check Price and Availability of UFWXSFSMIFKKPH-QFIPXVFZSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of UFWXSFSMIFKKPH-QFIPXVFZSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for UFWXSFSMIFKKPH-QFIPXVFZSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for UFWXSFSMIFKKPH-QFIPXVFZSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of UFWXSFSMIFKKPH-QFIPXVFZSA-N available by request